Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center

Patient age as a predictive factor in biochemical recurrence following brachytherapy: Oncological outcomes at a single center

Background: Iodine-125 low-dose-rate brachytherapy (LDR-BT) is a treatment modality utilized in both localized and advanced prostate cancer (PCa). We aimed to evaluate the long-term oncological outcomes in patients with PCa who underwent LDR-BT, at a single institution in Japan. Methods: We retrospe...

Full description

Bibliographic Details
Main Authors: Shinichi Takeuchi, Koji Iinuma, Masahiro Nakano, Makoto Kawase, Daiki Kato, Kota Kawase, Manabu Takai, Keita Nakane, Masaya Ito, Tomoyasu Kumano, Masayuki Matsuo, Takuya Koie
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Prostate International
Subjects:
Biochemical recurrence
Brachytherapy
Patients' age
Prostate cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888222000253

Internet

http://www.sciencedirect.com/science/article/pii/S2287888222000253

Similar Items